在黑色素瘤中透瘤的淋巴细胞疗法:准备好了吗?
Rachel Woodford1,2, Paul Lorigan3,4, Deemesh Oudit5
1Advanced Immunotherapy & Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
British journal of cancer
|February 18, 2026
概括
瘤透淋巴细胞 (TIL) 疗法对晚期黑色素瘤患者显示有前途. 国家协调对于其复杂的实施,制造和成本效益高的整合到癌症治疗中至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
背景情况:
- 瘤浸淋巴细胞 (TIL) 治疗为晚期黑色素瘤提供了持久的临床益处.
- 最近FDA对Lifileucel (Amtagvi) 的批准意味着在固体瘤中先进治疗药物 (ATMP) 的里程碑.
- 在英国和欧洲,Lifileucel的监管和资金决定正在等待.
研究的目的:
- 审查TIL治疗的证据基础.
- 概述国家采用TIL治疗的关键考虑因素.
- 讨论将TIL治疗纳入常规护理中的挑战和策略.
主要方法:
- 对临床试验数据和监管批准的审查.
- 对后勤,基础设施和健康经济因素的分析.
- 考虑国家协调战略和协作网络.
主要成果:
- TIL治疗需要在患者选择,制造和管理之间进行复杂的协调.
- 专门的基础设施和综合护理途径对于成功实施至关重要.
- 商业集中可能会缓解物流问题,但成本需要经济评估.
结论:
- 需要国家协调的努力来协调临床优先级和监督.
- 建议投资于分散的制造能力和像ATTC网络这样的协作网络.
- 阶段性,经验主导的推出与以股权为重点的服务设计对于成功采用至关重要.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.1K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.9K
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
